Can Hydroxychloroquine Contain Spread of COVID-19 in Patients?

The anti-malarial drug hydroxychloroquine has shot to fame, owing to its efficacy in shortening the time taken for recovery from COVID-19. Fewer side effects associated with these medicines are encouraging manufacturers in the hydroxychloroquine drugs market to boost their output capacities. Over-the-counter distribution and inexpensive nature of hydroxychloroquine are being preferred by caretakers in home quarantine environments. However, these drugs are under scrutiny for lab-controlled testing, since there is lack of evidence about human trails.

It has been found that hydroxychloroquine alone or in combination with azithromycin can reduce virus levels quicker. Such findings have prompted drug regulators in several countries, including India to approve the drug in restricted settings. Hydroxychloroquine is found to trigger a hyperactive response by the immune system, which helps to minimize the symptoms. These factors are likely to drive the hydroxychloroquine drugs market during the forecast period.

hydroxychloroquine drugs market segmentation

Request a sample to get extensive insights into the Hydroxychloroquine Drugs Market

High Prevalence of Childhood Arthritis Cases and Autoimmune Diseases Triggers Market Growth

The hydroxychloroquine drugs market is predicted to clock a robust CAGR of 10% during the forecast period. Hydroxychloroquine (Plaquenil) is considered as a disease-modifying anti-rheumatic drug. The high prevalence of joint pain and long-term disability in individuals has catalyzed the demand for hydroxychloroquine drugs. Plaquenil is being highly publicized for effectively reducing pain and swelling of arthritis.

An alarmingly high number of childhood arthritis cases and other autoimmune diseases are acting as key drivers for the hydroxychloroquine drugs market. However, the drug may lead to severe hypoglycemia. Thus, diabetic patients are advised to regularly monitor their blood sugar levels. On the other hand, it has been found that hydroxychloroquine is not effective against malaria in areas where chloroquine resistance has been reported. Hence, pharma companies are advocating a better understanding of poor quality drugs on malaria control.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Pooled Analysis of Hydroxychloroquine Provides Drug Resistance Status

Hydroxychloroquine drugs are the gold standard for the treatment of malaria. However, in many cases, healthcare professionals have encountered drug resistance in patients, which is likely to affect the growth of the hydroxychloroquine drugs market. Poorly administered medicines and substandard treatments are affecting the sales of hydroxychloroquine drugs. Hence, manufacturers in the hydroxychloroquine drugs market are taking ques from the WorldWide Antimalarial Resistance Network (WWARN), which is facilitating study groups that generate a pooled analysis of the efficacy and safety of hydroxychloroquine drugs.

Freely available training courses, tools and resources are being employed to provide regional researchers with the knowledge and skills to generate high-quality antimalarial clinical data. As such, the FDA (Food and Drug Administration) approval for hydroxychloroquine is being highly preferred for rheumatoid arthritis and systemic lupus erythematosis treatment.

Decreased Disease Flares to Offset Disadvantages of Toxicity

The global hydroxychloroquine drugs market is expected to cross US$ 1.9 Bn by 2030, as manufacturers are increasing their output capacities that cater to the treatment of systemic lupus erythematosus. Research into the wide-ranging effects of hydroxychloroquine reveals that several benefits involving decrease in disease flares and decline in the number of antigen-presenting cells in the skin are bolstering market growth.

The decline in the damage from disease over time and the hydroxychloroquine’s ability to delay absorption of ultraviolet light (UV) are helping pharma companies boost their production capacities. However, patients with retinal dystrophy or macular degeneration are susceptible to toxicity due to hydroxychloroquine administration. Hence, companies in the hydroxychloroquine drugs market are encouraging patients to conduct annual examinations with qualified retina specialists to control toxicity levels.

hydroxychloroquine drugs market infographic

Stuck in a neck-to-neck competition with other brands? Request a custom report on Hydroxychloroquine Drugs Market

Analysts’ Viewpoint

Companies in the hydroxychloroquine drugs market have increased their output capacities during the COVID-19 pandemic. However, the FDA has issued a caution against hydroxychloroquine outside of hospital settings due to the potential risk of heart rhythm problems. Juvenile idiopathic arthritis and high prevalence of lupus in individuals are boosting the growth of the hydroxychloroquine drugs market. However, issues of drug resistance are being encountered by several healthcare professionals. Hence, pharma companies are designing data visualization and mapping tools to track the spread of drug resistance. Such data is being handed over to government-led surveillance agencies to introduce high-quality drugs in the market.

Hydroxychloroquine Drugs Market: Overview

  • Hydroxychloroquine (HCQ) belongs to a class of drugs called antimalarials. It is used to treat rheumatoid arthritis and systemic lupus erythematosus by decreasing the activity of the immune system. In 2020, hydroxychloroquine gained popularity as a treatment for coronavirus (COVID-19). However, HCQ tablets are currently under clinical trial as a possible treatment for COVID-19 and their efficacy in treating COVID-19 is yet to be demonstrated in the studies.
  • Rise in prevalence of malaria and rheumatoid arthritis, and increase in geriatric population are projected to drive the global hydroxychloroquine drugs market. Surge in product launches and approvals are anticipated to augment the global market in the near future.

Hydroxychloroquine Drugs Market: Key Drivers

  • Hydroxychloroquine is FDA-approved to treat or prevent malaria. Hydroxychloroquine is also approved for treatment of autoimmune conditions such as chronic discoid lupus erythematosus, systemic lupus erythematosus in adults, and rheumatoid arthritis. According to CDC, nearly half the world's population lives in areas at risk of malaria transmission in 91 countries and territories. In 2016, malaria caused an estimated 216 million clinical episodes and 445,000 deaths, which increased to an estimated 228 million cases and 405,000 deaths in 2018. Majority of deaths occurred in the WHO African Region.
  • Disease outbreaks such as coronavirus also boost the demand for the drug. According the WHO, as on November 23, 2020, 58,425,681 confirmed cases of COVID-19, including 1,385,218 deaths, were reported globally.
  • Older people are at high risk of rheumatoid arthritis. Depending on their underlying health, older adults with rheumatoid arthritis could have to cope with multiple coexisting diseases, polypharmacy, and impaired functional ability. According the CDC, from 2013 to 2015, 49.6% of people aged 65 years or older in the U.S. reported doctor-diagnosed arthritis.

Increase in Product Launches and Approvals

  • Product launch strategies aim to boost revenue. More than 25% of total revenue and profits across industries comes from the launch of new products. In April 2020, Lincoln Pharmaceuticals received the FDA approval to manufacture hydroxychloroquine (HCQ) tablets and hydroxychloroquine sulfate tablets. After necessary approval from the Directorate General of Foreign Trade (DGFT), the company will be able to export these products. Rise in number of product approvals is expected to propel the global market during the forecast period.

Market Segmentation: Hydroxychloroquine Drugs Market

  • In terms of disease indication, the global hydroxychloroquine drugs market has been classified into malaria, rheumatoid arthritis, COVID-19, systemic lupus erythematosus, and others
  • Based on distribution channel, the global hydroxychloroquine drugs market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies
  • Each of the segments has been analyzed in detail for trends, recent trends & developments, drivers, restraints, opportunities, and useful insights. The hydroxychloroquine drugs market report provides current and future revenue (US$ Mn) for each of these segments for the period from 2018 to 2030, considering 2019 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2020 to 2030, along with market size estimations.

Regional Overview: Hydroxychloroquine Drugs Market

  • In terms of region, the global hydroxychloroquine drugs market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
  • Stringent government regulations, presence of large-scale research units, and awareness about drug safety are the key factors projected to augment the market in North America. The market in Asia Pacific is driven by favorable business environment and government initiatives to improve healthcare infrastructure. Moreover, increase in focus on research & development is anticipated to augment the market in the region.
  • The current and future market sizes in terms of value (US$ Mn) of these regional markets and major countries have been provided in the report for the period from 2018 to 2030, along with their CAGRs for the period from 2020 to 2030
  • The study also offers a list of recommendations, highlights, and useful insights of the market, which are estimated to help new companies willing to enter the market and existing companies to increase market share and in the decision-making process

Major Players

  • The report concludes with company profiles section that includes key information about the major players in the global hydroxychloroquine drugs market
  • Leading players analyzed in the report are
    • Sanofi
    • Amneal Pharmaceuticals, Inc.
    • Mylan N.V.
    • Teva Pharmaceutical Industries Ltd.
    • Novartis AG
    • Zydus Cadila
    • Dr. Reddy’s Laboratories Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Lupin Limited
    • Prasco Laboratories
  • Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Hydroxychloroquine Drugs Market – Segmentation

TMR’s study on the global hydroxychloroquine drugs market includes information divided into three segments: disease indication, distribution channel, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global hydroxychloroquine drugs market have been discussed in detail.

Disease Indication

  • Malaria
  • Rheumatoid Arthritis
  • COVID-19
  • Systemic Lupus Erythematosus
  • Others

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

Hydroxychloroquine drugs market to surpass valuation US$ 1.9 Bn by 2030

Hydroxychloroquine drugs market is projected to expand at a CAGR of 10% from 2020 to 2030

Hydroxychloroquine drugs market is driven by rise in prevalence of malaria and rheumatoid arthritis, and increase in geriatric population

North America accounted for a major share of the global hydroxychloroquine drugs market and the trend is anticipated to continue during the forecast period

Key players in the global market include Sanofi, Amneal Pharmaceuticals, Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Novartis AG, Zydus Cadila

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hydroxychloroquine Drugs Market

4. Market Overview

    4.1.  Introduction & Overview

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunities

    4.3. Global Hydroxychloroquine Drugs Market Analysis and Forecast, 2018–2030

5. Market Outlook

    5.1. COVID-19 Pandemics Impact on Industry

    5.2. Regulatory Scenario by Region/globally

    5.3. Disease Prevalence & Incidence Rate globally with key countries

6. Global Hydroxychloroquine Drugs Market Analysis and Forecast, by Disease Indication

    6.1. Introduction & Definition    

    6.2. Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030

        6.2.1. Malaria

        6.2.2. Rheumatoid Arthritis

        6.2.3. COVID-19

        6.2.4. Systemic Lupus Erythematosus

        6.2.5. Others

    6.3. Global Hydroxychloroquine Drugs Market Attractiveness Analysis, by Disease Indication

7. Global Hydroxychloroquine Drugs Market Analysis and Forecast, by Distribution Channel

    7.1. Introduction & Definition    

    7.2. Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

        7.2.1. Hospital Pharmacies

        7.2.2. Retail Pharmacies

        7.2.3. Online Pharmacies

    7.3. Global Hydroxychloroquine Drugs Market Attractiveness Analysis, by Distribution Channel

8. Global Hydroxychloroquine Drugs Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Global Hydroxychloroquine Drugs Market Attractiveness Analysis, by Region

9. North America Hydroxychloroquine Drugs Market Analysis and Forecast

    9.1. Introduction

    9.2. North America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030

        9.2.1. Malaria

        9.2.2. Rheumatoid Arthritis

        9.2.3. COVID-19

        9.2.4. Systemic Lupus Erythematosus

        9.2.5. Others

    9.3. North America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

        9.3.1. Hospital Pharmacies

        9.3.2. Retail Pharmacies

        9.3.3. Online Pharmacies

    9.4. North America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country, 2018–2030

        9.4.1. U.S.

        9.4.2. Canada

    9.5. North America Hydroxychloroquine Drugs Market Attractiveness Analysis

        9.5.1. By Disease Indication

        9.5.2. By Distribution Channel

        9.5.3. By Country

10. Europe Hydroxychloroquine Drugs Market Analysis and Forecast

    10.1. Introduction

    10.2. Europe Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030

        10.2.1. Malaria

        10.2.2. Rheumatoid Arthritis

        10.2.3. COVID-19

        10.2.4. Systemic Lupus Erythematosus

        10.2.5. Others

    10.3. Europe Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

        10.3.1. Hospital Pharmacies

        10.3.2. Retail Pharmacies

        10.3.3. Online Pharmacies

    10.4. Europe Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Europe Hydroxychloroquine Drugs Market Attractiveness Analysis

        10.5.1. By Disease Indication

        10.5.2. By Distribution Channel

        10.5.3. By Country/Sub-region

11. Asia Pacific Hydroxychloroquine Drugs Market Analysis and Forecast

    11.1. Introduction

    11.2. Asia Pacific Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030

        11.2.1. Malaria

        11.2.2. Rheumatoid Arthritis

        11.2.3. COVID-19

        11.2.4. Systemic Lupus Erythematosus

        11.2.5. Others

    11.3. Asia Pacific Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

        11.3.1. Hospital Pharmacies

        11.3.2. Retail Pharmacies

        11.3.3. Online Pharmacies

    11.4. Asia Pacific Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Asia Pacific Hydroxychloroquine Drugs Market Attractiveness Analysis

        11.5.1. By Disease Indication

        11.5.2. By Distribution Channel

        11.5.3. By Country/Sub-region

12. Latin America Hydroxychloroquine Drugs Market Analysis and Forecast

    12.1. Introduction

    12.2. Latin America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030

        12.2.1. Malaria

        12.2.2. Rheumatoid Arthritis

        12.2.3. COVID-19

        12.2.4. Systemic Lupus Erythematosus

        12.2.5. Others

    12.3. Latin America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

        12.3.1. Hospital Pharmacies

        12.3.2. Retail Pharmacies

        12.3.3. Online Pharmacies

    12.4. Latin America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Latin America Hydroxychloroquine Drugs Market Attractiveness Analysis

        12.5.1. By Disease Indication

        12.5.2. By Distribution Channel

        12.5.3. By Country/Sub-region

13. Middle East & Africa Hydroxychloroquine Drugs Market Analysis and Forecast

    13.1. Introduction

    13.2. Middle East & Africa Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030

        13.2.1. Malaria

        13.2.2. Rheumatoid Arthritis

        13.2.3. COVID-19

        13.2.4. Systemic Lupus Erythematosus

        13.2.5. Others

    13.3. Middle East & Africa Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

        13.3.1. Hospital Pharmacies

        13.3.2. Retail Pharmacies

        13.3.3. Online Pharmacies

    13.4. Middle East & Africa Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Middle East & Africa Hydroxychloroquine Drugs Market Attractiveness Analysis

        13.5.1. By Disease Indication

        13.5.2. By Distribution Channel

        13.5.3. By Country/Sub-region

14. Competitive Landscape

    14.1. Market Position Analysis, by Company, 2019

    14.2. Company Profiles

        14.2.1. Sanofi

            14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.1.2. Growth Strategies

            14.2.1.3. SWOT Analysis

        14.2.2. Amneal Pharmaceuticals, Inc.

            14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.2.2. Growth Strategies

            14.2.2.3. SWOT Analysis

        14.2.3. Mylan N.V.

            14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.3.2. Growth Strategies

            14.2.3.3. SWOT Analysis

        14.2.4. Teva Pharmaceutical Industries Ltd.

            14.2.4.1. Company Overview (HQ, Business Segments)

            14.2.4.2. Growth Strategies

            14.2.4.3. SWOT Analysis

        14.2.5. Novartis AG

            14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.5.2. Growth Strategies

            14.2.5.3. SWOT Analysis

        14.2.6. Zydus Cadila

            14.2.6.1. Company Overview (HQ, Business Segments)

            14.2.6.2. Growth Strategies

            14.2.6.3. SWOT Analysis

        14.2.7. Dr. Reddy’s Laboratories Ltd.

            14.2.7.1. Company Overview (HQ, Business Segments)

            14.2.7.2. Growth Strategies

            14.2.7.3. SWOT Analysis

        14.2.8. Sun Pharmaceutical Industries Ltd.

            14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.8.2. Growth Strategies

            14.2.8.3. SWOT Analysis

        14.2.9. Lupin Limited

            14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.9.2. Growth Strategies

            14.2.9.3. SWOT Analysis

        14.2.10. Prasco Laboratories

            14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.10.2. Company Financials

            14.2.10.3. Growth Strategies

            14.2.10.4. SWOT Analysis

List of Tables

Table 01: Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030

Table 02: Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 03: Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 04: North America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Country, 2018–2030

Table 05: North America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018–2030

Table 06: North America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 07: Europe Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 08: Europe Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018–2030

Table 09: Europe Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 10: Asia Pacific Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 11: Asia Pacific Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018–2030

Table 12: Asia Pacific Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 13: Latin America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 14: Latin America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018–2030

Table 15: Latin America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 16: Middle East & Africa Remote Patient Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 17: Middle East & Africa Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018–2030

Table 18: Middle East & Africa Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018–2030

List of Figures

Figure 1: Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, 2018–2030

Figure 2: Global Hydroxychloroquine Drugs Market Value Share, by Disease Indication, 2019

Figure 3: Global Hydroxychloroquine Drugs Market Value Share, by Distribution Channel, 2019

Figure 4: Global Hydroxychloroquine Drugs Market Value Share Analysis, by Disease Indication, 2019 and 2030

Figure 5: Global Hydroxychloroquine Drugs Market Attractiveness Analysis, by Disease Indication, 2020–2030

Figure 6: Global Hydroxychloroquine Drugs Market Revenue (US$ Mn), by Malaria, 2018–2030

Figure 7: Global Hydroxychloroquine Drugs Market Revenue (US$ Mn), by Rheumatoid Arthritis, 2018–2030

Figure 8: Global Hydroxychloroquine Drugs Market Revenue (US$ Mn), by COVID-19, 2018–2030

Figure 9: Global Hydroxychloroquine Drugs Market Revenue (US$ Mn), by Systemic Lupus Erythematosus, 2018–2030

Figure 10: Global Hydroxychloroquine Drugs Market Revenue (US$ Mn), by Others, 2018–2030

Figure 11: Global Hydroxychloroquine Drugs Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 12: Global Hydroxychloroquine Drugs Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 13: Global Hydroxychloroquine Drugs Market Revenue (US$ Mn), by Hospital Pharmacies, 2018–2030

Figure 14: Global Hydroxychloroquine Drugs Market Revenue (US$ Mn), by Retail Pharmacies, 2018–2030

Figure 15: Global Hydroxychloroquine Drugs Market Revenue (US$ Mn), by Online Pharmacies, 2018–2030

Figure 16: Global Hydroxychloroquine Drugs Market Value Share Analysis, by Region, 2019 and 2030

Figure 17: Global Hydroxychloroquine Drugs Market Attractiveness Analysis, by Region, 2020–2030

Figure 18: North America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 19: North America Hydroxychloroquine Drugs Market Value Share (%), by Country, 2019 and 2030

Figure 20: North America Hydroxychloroquine Drugs Market Attractiveness, by Country, 2020–2030

Figure 21: North America Hydroxychloroquine Drugs Market Value Share (%), by Disease Indication, 2019 and 2030

Figure 22: North America Hydroxychloroquine Drugs Market Attractiveness, by Disease Indication, 2020–2030

Figure 23: North America Hydroxychloroquine Drugs Market Value Share (%), by Distribution Channel, 2019 and 2030

Figure 24: North America Hydroxychloroquine Drugs Market Attractiveness, by Distribution Channel, 2020–2030

Figure 25: Europe Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 26: Europe Hydroxychloroquine Drugs Market Value Share, by Country/Sub-region, 2019–2030

Figure 27: Europe Hydroxychloroquine Drugs Market Attractiveness, by Country/Sub-region, 2019–2030

Figure 28: Europe Hydroxychloroquine Drugs Market Value Share (%), by Disease Indication, 2019 and 2030

Figure 29: Europe Hydroxychloroquine Drugs Market Attractiveness, by Disease Indication, 2020–2030

Figure 30: Europe Hydroxychloroquine Drugs Market Value Share (%), by Distribution Channel, 2019 and 2030

Figure 31: Europe Hydroxychloroquine Drugs Market Attractiveness, by Distribution Channel, 2020–2030

Figure 32: Asia Pacific Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 33: Asia Pacific Hydroxychloroquine Drugs Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 34: Asia Pacific Hydroxychloroquine Drugs Market Attractiveness, by Country/Sub-region, 2020–2030

Figure 35: Asia Pacific Hydroxychloroquine Drugs Market Value Share (%), by Disease Indication, 2019 and 2030

Figure 36: Asia Pacific Hydroxychloroquine Drugs Market Attractiveness, by Disease Indication, 2020–2030

Figure 37: Asia Pacific Hydroxychloroquine Drugs Market Value Share (%), by Distribution Channel, 2019 and 2030

Figure 38: Asia Pacific Hydroxychloroquine Drugs Market Attractiveness, by Distribution Channel, 2020–2030

Figure 39: Latin America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 40: Latin America Hydroxychloroquine Drugs Market Value Share, by Country/Sub-region, 2019–2030

Figure 41: Latin America Hydroxychloroquine Drugs Market Attractiveness, by Country/Sub-region, 2019–2030

Figure 42: Latin America Hydroxychloroquine Drugs Market Value Share (%), by Disease Indication, 2019 and 2030

Figure 43: Latin America Hydroxychloroquine Drugs Market Attractiveness, by Disease Indication, 2020–2030

Figure 44: Latin America Hydroxychloroquine Drugs Market Value Share (%), by Distribution Channel, 2019 and 2030

Figure 45: Latin America Hydroxychloroquine Drugs Market Attractiveness, by Distribution Channel, 2020–2030

Figure 46: Middle East & Africa Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 47: Middle East & Africa Remote Patient Monitoring Devices Market Value Share, by Country/Sub-region, 2019–2030

Figure 48: Middle East & Africa Remote Patient Monitoring Devices Market Attractiveness, by Country/Sub-region, 2019–2030

Figure 49: Middle East & Africa Hydroxychloroquine Drugs Market Value Share (%), by Disease Indication, 2019 and 2030

Figure 50: Middle East & Africa Hydroxychloroquine Drugs Market Attractiveness, by Disease Indication, 2020–2030

Figure 51: Middle East & Africa Hydroxychloroquine Drugs Market Value Share (%), by Distribution Channel, 2019 and 2030

Figure 52: Middle East & Africa Hydroxychloroquine Drugs Market Attractiveness, by Distribution Channel, 2020–2030

Figure 53: Global Hydroxychloroquine Drugs Market Share Analysis, by Company, 2019

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Hydroxychloroquine Drugs Market